 | PARKINSON'S DISEASE: The Life Cycle of the Dopamine Neuron
Copyright © 2003 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 991:199-213 (2003)
© 2003 New York Academy of Sciences
Pathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human Disorder
THOMAS WICHMANN AND
MAHLON R. DeLONG
Department of Neurology, Emory University School of Medicine, Atlanta Georgia 30322, USA
Address for correspondence: Thomas Wichmann, M. D., Department of Neurology, Emory University, Suite 6000, Woodruff Memorial Research Building, 1639 Pierce Drive, Atlanta, GA 30322. Voice: 404-727-3818; fax: 404-727-3157.
twichma{at}emory.edu
Ann. N.Y. Acad. Sci. 991: 199-213 (2003).
The striatum is viewed as the principal input structure of the basal ganglia, while the internal pallidal segment (GPi) and the substantia nigra pars reticulata (SNr) are output structures. Input and output structures are linked via a monosynaptic "direct" pathway and a polysynaptic "indirect" pathway involving the external pallidal segment (GPe) and the subthalamic nucleus (STN). According to current schemes, striatal dopamine (DA) enhances transmission along the direct pathway (via D1 receptors), and reduces transmission over the indirect pathway (via D2 receptors). DA also acts on receptors in GPe, GPi, SNr, and STN. Electrophysiologic and other studies in primates rendered parkinsonian by treatment with the dopaminergic neurotoxin MPTP have demonstrated a reduction of neuronal activity of GPe and an increase of neuronal discharge in STN, GPi. and SNr. These findings are compatible with the view that striatal DA loss results in increased activity over the indirect pathway. Prominent bursting, oscillatory discharge patterns, and increased synchronization of neighboring neurons are found throughout the basal ganglia. These may result from changes in the activity of local circuits (e.g., the GPe-STN "pacemaker") or from more global abnormalities of the basal ganglia-thalamocortical network. These findings have been replicated in human patients undergoing microelectrode-guided stereotactic procedures targeted at GPi or STN. PET studies in patients with Parkinson's disease have lent further support to the proposed circuit abnormalities. The current models of basal ganglia function have recently been criticized. For instance, the strict separation of direct and indirect pathways and the segregation of D1 and D2 receptors have been questioned, and the almost complete absence of motor side effects of pallidal or thalamic lesions in human patients and animals is inconsistent. These results suggest that changes in discharge patterns and synchronization between basal ganglia neurons, abnormal network interactions, and compensatory mechanisms are at least as important in the pathopohysiology of parkinsonism as changes in discharge rates in individual basal ganglia nuclei. Lesions of GPi or STN are effective in treating parkinsonism, because they reduce or abolish abnormal basal ganglia output, enabling remaining circuits to function more normally.
Key Words: MPTP • primate • pathophysiology • pallidum • subthalamic nucleus • substantia nigra
This article has been cited by other articles:
|
|
|
|
 
N. Sawamoto, P. Piccini, G. Hotton, N. Pavese, K. Thielemans, and D. J. Brooks
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease
Brain,
May 1, 2008;
131(5):
1294 - 1302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. P. Lin, M. Carbon, C. Tang, A. Y. Mogilner, D. Sterio, A. Beric, V. Dhawan, and D. Eidelberg
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease
Brain,
May 1, 2008;
131(5):
1373 - 1380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Feigin, M. G. Kaplitt, C. Tang, T. Lin, P. Mattis, V. Dhawan, M. J. During, and D. Eidelberg
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease
PNAS,
December 4, 2007;
104(49):
19559 - 19564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Ibanez-Sandoval, L. Carrillo-Reid, E. Galarraga, D. Tapia, E. Mendoza, J. C. Gomora, J. Aceves, and J. Bargas
Bursting in Substantia Nigra Pars Reticulata Neurons In Vitro: Possible Relevance for Parkinson Disease
J Neurophysiol,
October 1, 2007;
98(4):
2311 - 2323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Kliem, N. T. Maidment, L. C. Ackerson, S. Chen, Y. Smith, and T. Wichmann
Activation of Nigral and Pallidal Dopamine D1-Like Receptors Modulates Basal Ganglia Outflow in Monkeys
J Neurophysiol,
September 1, 2007;
98(3):
1489 - 1500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Binkofski, K. Reetz, C. Gaser, R. Hilker, J. Hagenah, K. Hedrich, T. van Eimeren, A. Thiel, C. Buchel, P. P. Pramstaller, et al.
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia
Neurology,
August 28, 2007;
69(9):
842 - 850.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar, V. Dhawan, and D. Eidelberg
Changes in network activity with the progression of Parkinson's disease
Brain,
July 1, 2007;
130(7):
1834 - 1846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Tecuapetla, L. Carrillo-Reid, J. Bargas, and E. Galarraga
Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses
PNAS,
June 12, 2007;
104(24):
10258 - 10263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kuwajima, M. H. Dehoff, T. Furuichi, P. F. Worley, R. A. Hall, and Y. Smith
Localization and Expression of Group I Metabotropic Glutamate Receptors in the Mouse Striatum, Globus Pallidus, and Subthalamic Nucleus: Regulatory Effects of MPTP Treatment and Constitutive Homer Deletion
J. Neurosci.,
June 6, 2007;
27(23):
6249 - 6260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E A C Pereira and T Z Aziz
Parkinson's disease and primate research: past, present, and future.
Postgrad. Med. J.,
May 1, 2006;
82(967):
293 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Wichmann and J. Soares
Neuronal Firing Before and After Burst Discharges in the Monkey Basal Ganglia Is Predictably Patterned in the Normal State and Altered in Parkinsonism
J Neurophysiol,
April 1, 2006;
95(4):
2120 - 2133.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Marceglia, G. Foffani, A. M. Bianchi, G. Baselli, F. Tamma, M. Egidi, and A. Priori
Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease
J. Physiol.,
March 15, 2006;
571(3):
579 - 591.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I. Kass and I. M. Mintz
Silent plateau potentials, rhythmic bursts, and pacemaker firing: Three patterns of activity that coexist in quadristable subthalamic neurons
PNAS,
January 3, 2006;
103(1):
183 - 188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Miller and H. J. Federoff
Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model Systems
Neuroscientist,
December 1, 2005;
11(6):
539 - 549.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Baufreton, Z.-T. Zhu, M. Garret, B. Bioulac, S. W. Johnson, and A. I. Taupignon
Dopamine receptors set the pattern of activity generated in subthalamic neurons
FASEB J,
November 1, 2005;
19(13):
1771 - 1777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Xiang, L. Wang, and S. T. Kitai
Modulation of Spontaneous Firing in Rat Subthalamic Neurons by 5-HT Receptor Subtypes
J Neurophysiol,
March 1, 2005;
93(3):
1145 - 1157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Soares, M. A. Kliem, R. Betarbet, J. T. Greenamyre, B. Yamamoto, and T. Wichmann
Role of External Pallidal Segment in Primate Parkinsonism: Comparison of the Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism and Lesions of the External Pallidal Segment
J. Neurosci.,
July 21, 2004;
24(29):
6417 - 6426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
